Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-006314
Filing Date
2025-03-03
Accepted
2025-03-03 20:29:56
Documents
2
Period of Report
2025-03-01

Document Format Files

Seq Description Document Type Size
1 form3-03042025_010353.html 3  
1 form3-03042025_010353.xml 3 11128
2 ex24-03042025_010356.htm EX-24 3317
  Complete submission text file 0001415889-25-006314.txt   15825
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064
Business Address
Shroff Eric (Reporting) CIK: 0002058129 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-02189 | Film No.: 25700985